Skip to content
OpenCapital
Get started

Ecolab ECL Global Healthcare And Life Sciences — Operating Income

Other segment segments

Global Institutional
$347.5M+12.7%
Water Services
$297.8M+6.9%
Corporate
-$114.8M-37.5%
Global Pest Elimination
$51.7M+8.4%

Similar metrics at other companies

STERIS logo
STEHealthcare — Operating Income (Loss)
$258.1M+4.5%
STERIS logo
STEHealthcare Products Member — Operating Income
$105.91M-0.7%
Agilent Technologies logo
ALife Sciences and Applied Markets — Operating Income (Loss)
$233M-2.9%
STERIS logo
STEHealthcare Specialty Services — Operating Income
$15.95M-19.4%
STERIS logo
STELife Sciences: — Segment operating income
$61.8M+6.4%
Leidos Holdings logo
LDOSHealth — Operating Income (Loss)
$147M+70.9%

Other financials

Income statement

See full
Revenue$4.1B+10.0%
Gross profit$1.8B+8.3%
Operating income$622.0M+12.0%
Net income$432.6M+7.5%
EPS (diluted)$1.52+7.8%

Balance sheet

See full
Cash & equivalents$519.8M-55.3%
Total debt$167.3M+13.6%
Total equity$10.0B+12.7%
Total assets$25.0B+12.0%

Cash flow

See full
Operating cash flow$445.9M+20.7%
CapEx$348.5M+46.5%
Free cash flow$97.4M-25.9%

Valuation

See full
Market cap$75.72B+4.5%
Enterprise value$75.37B+5.5%
P/E36×+1.5×
P/S4.6×0.0×

Profitability

See full
Gross margin44.3%+0.6pp
Operating margin17%-1.1pp
Net margin12.8%-0.6pp

Returns & leverage

See full
Return on equity22.3%-2.3pp
Debt / equity0×0.0×
Current ratio1×-0.3×

Where this comes from

Reported directly by Ecolab in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Ecolab’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ecolab's global healthcare and life sciences — operating income.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ecolab's global healthcare and life sciences — operating income?
Ecolab (ECL) reported global healthcare and life sciences — operating income of $37.5M in Q1 2026.
How has Ecolab's global healthcare and life sciences — operating income changed year-over-year?
Ecolab's global healthcare and life sciences — operating income increased by 21.0% year-over-year, from $31M to $37.5M.
What is the long-term trend for Ecolab's global healthcare and life sciences — operating income?
Over 4 years (2021 to 2025), Ecolab's global healthcare and life sciences — operating income has grown at a -0.4% compound annual growth rate (CAGR), from $152.3M to $149.9M.
What does global healthcare and life sciences — operating income mean?
The profit or loss generated by the segment from its core business operations.
How do you interpret global healthcare and life sciences — operating income?
Higher operating income indicates superior segment profitability and effective cost control.
How does global healthcare and life sciences — operating income compare across companies?
Comparable to 'Segment Operating Profit' or 'EBIT' reported by competitors in the healthcare services and industrial chemicals sectors.